Direct oral anticoagulants (DOAC s) have quickly become attractive alternatives to the long‐
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …

Atrial fibrillation (AF) is a major worldwide public health problem, and AF in association with
valvular heart disease (VHD) is also common. However, management strategies for this …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Background The effects of rivaroxaban in patients with atrial fibrillation and a bioprosthetic
mitral valve remain uncertain. Methods In this randomized trial, we compared rivaroxaban …

Atrial fibrillation (AF) is a common arrhythmia in patients with aortic stenosis. When these
patients are treated medically or by surgical aortic valve replacement, AF is associated with …

There are currently a wide modalities of interventional strategies-both transcatheter and
surgical-which can be indicated for patients with valvular heart diseases (VHD), with the …

Atrial Fibrillation (AF) has become a major global health concern being the most common
sustained arrhythmia in clinical practice. Risk factors for AF include congestive heart failure …

In the recent years, there has been significant transformation in the management of valvular
heart disease (VHD), as a result of new minimally invasive technologies, such as the …

Atualmente, há grande variedade de estratégias intervencionistas-tanto transcateter, quanto
cirúrgicas-que podem ser indicadas para pacientes portadores de valvopatia cardíaca, com …